These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 38693534)

  • 1. Campylobacter jejuni virulence factors: update on emerging issues and trends.
    Tikhomirova A; McNabb ER; Petterlin L; Bellamy GL; Lin KH; Santoso CA; Daye ES; Alhaddad FM; Lee KP; Roujeinikova A
    J Biomed Sci; 2024 May; 31(1):45. PubMed ID: 38693534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbe Profile:
    Gundogdu O; Wren BW
    Microbiology (Reading); 2020 Mar; 166(3):230-232. PubMed ID: 32228803
    [No Abstract]   [Full Text] [Related]  

  • 3. The pathogenesis of Campylobacter jejuni.
    Wallis MR
    Br J Biomed Sci; 1994 Mar; 51(1):57-64. PubMed ID: 7841837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of chemotaxis during Campylobacter jejuni colonisation and pathogenesis.
    Korolik V
    Curr Opin Microbiol; 2019 Feb; 47():32-37. PubMed ID: 30476739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms.
    Dasti JI; Tareen AM; Lugert R; Zautner AE; Gross U
    Int J Med Microbiol; 2010 Apr; 300(4):205-11. PubMed ID: 19665925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Campylobacter jejuni: targeting host cells, adhesion, invasion, and survival.
    Kemper L; Hensel A
    Appl Microbiol Biotechnol; 2023 May; 107(9):2725-2754. PubMed ID: 36941439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selected mechanisms of pathogenicity of Campylobacter jejuni].
    Rokosz-Chudziak N; Rastawicki W
    Med Dosw Mikrobiol; 2014; 66(1):47-58. PubMed ID: 25007513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Campylobacter jejuni--microtubule-dependent invasion.
    Kopecko DJ; Hu L; Zaal KJ
    Trends Microbiol; 2001 Aug; 9(8):389-96. PubMed ID: 11514222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic effects of Campylobacter infection.
    Nachamkin I
    Microbes Infect; 2002 Apr; 4(4):399-403. PubMed ID: 11932190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host epithelial cell invasion by Campylobacter jejuni: trigger or zipper mechanism?
    O Cróinín T; Backert S
    Front Cell Infect Microbiol; 2012; 2():25. PubMed ID: 22919617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of putative virulence traits of Campylobacter jejuni in regulating differential host immune responses.
    Singh A; Mallick AI
    J Microbiol; 2019 Apr; 57(4):298-309. PubMed ID: 30796746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Campylobacter jejuni: components for adherence to and invasion of eukaryotic cells.
    Lugert R; Gross U; Zautner AE
    Berl Munch Tierarztl Wochenschr; 2015; 128(3-4):90-7. PubMed ID: 25876267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting
    Elmi A; Nasher F; Dorrell N; Wren B; Gundogdu O
    Front Cell Infect Microbiol; 2020; 10():607704. PubMed ID: 33614526
    [No Abstract]   [Full Text] [Related]  

  • 14. Glycoconjugates play a key role in Campylobacter jejuni Infection: interactions between host and pathogen.
    Day CJ; Semchenko EA; Korolik V
    Front Cell Infect Microbiol; 2012; 2():9. PubMed ID: 22919601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of the virulence potential of Campylobacter jejuni strains by use of gene transcription analysis and a Caco-2 assay.
    Poli VF; Thorsen L; Olesen I; Wik MT; Jespersen L
    Int J Food Microbiol; 2012 Apr; 155(1-2):60-8. PubMed ID: 22336513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular Tight Junctions Prevent Effective
    Hatayama S; Shimohata T; Amano S; Kido J; Nguyen AQ; Sato Y; Kanda Y; Tentaku A; Fukushima S; Nakahashi M; Uebanso T; Mawatari K; Takahashi A
    Front Cell Infect Microbiol; 2018; 8():15. PubMed ID: 29441328
    [No Abstract]   [Full Text] [Related]  

  • 17. How a sugary bug gets through the day: recent developments in understanding fundamental processes impacting Campylobacter jejuni pathogenesis.
    Szymanski CM; Gaynor EC
    Gut Microbes; 2012; 3(2):135-44. PubMed ID: 22555465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barré syndrome.
    Louwen R; Horst-Kreft D; de Boer AG; van der Graaf L; de Knegt G; Hamersma M; Heikema AP; Timms AR; Jacobs BC; Wagenaar JA; Endtz HP; van der Oost J; Wells JM; Nieuwenhuis EE; van Vliet AH; Willemsen PT; van Baarlen P; van Belkum A
    Eur J Clin Microbiol Infect Dis; 2013 Feb; 32(2):207-26. PubMed ID: 22945471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of vaccine research and development for Campylobacter jejuni.
    Riddle MS; Guerry P
    Vaccine; 2016 Jun; 34(26):2903-2906. PubMed ID: 26973064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Campylobacter jejuni CiaD effector protein activates MAP kinase signaling pathways and is required for the development of disease.
    Samuelson DR; Eucker TP; Bell JA; Dybas L; Mansfield LS; Konkel ME
    Cell Commun Signal; 2013 Oct; 11():79. PubMed ID: 24144181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.